DSM-Firmenich AG (DSFIR) | Financial Analysis & Statements

DSM-Firmenich AG | Large-cap | Basic Materials

€90.50

0.27%

DSM-Firmenich AG vs Akzo Nobel N.V DSM-Firmenich AG vs IMCD N.V DSM-Firmenich AG vs OCI N.V DSM-Firmenich AG vs Holland Colours N.V DSM-Firmenich AG vs Prosus N.V DSM-Firmenich AG vs AEX Index | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 12.8B

Gross Profit 4.2B 33.17%

Operating Income 561.0M 4.38%

Net Income 280.0M 2.19%

Balance Sheet Metrics

Total Assets 33.7B

Total Liabilities 11.0B

Shareholders Equity 22.7B

Debt to Equity 0.49

Cash Flow Metrics

Operating Cash Flow 2.0B

Free Cash Flow 1.0B

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

DSM-Firmenich AG Income Statement From 2021 to 2024

Metric	2024	2023	2022	2021
Revenue	12.8B	10.6B	8.4B	11.4B
Cost of Goods Sold	8.6B	8.0B	5.7B	7.3B
Gross Profit	4.2B	2.6B	2.7B	4.2B
Operating Expenses	0	3.2B	2.1B	3.5B
Operating Income	561.0M	-507.0M	657.0M	816.0M
Pre-tax Income	427.0M	-647.0M	594.0M	645.0M
Income Tax	147.0M	-18.0M	124.0M	115.0M
Net Income	280.0M	2.2B	1.7B	880.0M
EPS (Diluted)	-	€9.14	€11.24	€5.78

Income Statement Trend

DSM-Firmenich AG Balance Sheet From 2022 to 2024

Metric	2024	2023	2022
Assets
Current Assets	8.8B	8.8B	8.1B
Non-Current Assets	24.9B	25.4B	9.3B
Total Assets	33.7B	34.3B	17.4B
Liabilities
Current Liabilities	4.4B	4.5B	2.6B
Non-Current Liabilities	6.7B	6.7B	4.0B
Total Liabilities	11.0B	11.2B	6.6B
Equity
Total Shareholders Equity	22.7B	23.1B	10.8B

Balance Sheet Composition

DSM-Firmenich AG Cash Flow Statement From 2022 to 2024

Metric	2024	2023	2022
Operating Activities
Net Income	2.0B	2.2B	1.7B
Operating Cash Flow	2.0B	2.7B	1.2B
Investing Activities
Capital Expenditures	-	-7.0M	-23.0M
Investing Cash Flow	430.0M	-110.0M	1.7B
Financing Activities
Dividends Paid	-667.0M	-582.0M	-345.0M
Financing Cash Flow	-1.4B	-686.0M	-536.0M
Free Cash Flow	1.0B	558.0M	281.0M

Cash Flow Trend

DSM-Firmenich AG Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 99.74

Forward P/E 30.94

Price to Book 1.10

Price to Sales 1.92

PEG Ratio 30.94

Profitability Ratios

Profit Margin 1.95%

Operating Margin 5.42%

Return on Equity 1.22%

Return on Assets 0.94%

Financial Health

Current Ratio 2.02

Debt to Equity 23.26

Beta 1.04

Per Share Data

EPS (TTM) €0.94

Book Value per Share €85.18

Revenue per Share €48.37

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
dsfir	24.6B	99.74	1.10	1.22%	1.95%	23.26
Akzo Nobel N.V	9.9B	21.27	2.14	10.71%	4.38%	121.08
IMCD N.V	6.6B	22.93	2.97	14.12%	5.86%	81.58
OCI N.V	1.6B	27.05	0.71	-7.87%	510.59%	35.77
Holland Colours N.V	97.2M	16.50	1.51	9.36%	5.24%	1.26
Prosus N.V	107.2B	10.61	3.53	18.09%	132.98%	34.53

Financial data is updated regularly. All figures are in the company's reporting currency.